Data / Form D filings / Instylla, Inc.
Instylla, Inc.: Form D filings
Instylla, Inc., a biotechnology company in Bedford, MA, filed 7 Form D notices with the SEC between 2017 and 2026. The latest, on July 28, 2026, reports $34.8 million sold of a $35 million offering to 29 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 201 BURLINGTON ROAD, Bedford, MA, 01730
- Phone
- (617) 510-3859
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1708696
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | Amendment | $35,034,025 | $34,783,984 | $250,041 | 29 | Jul 7, 2025 | sec.gov |
| Oct 23, 2025 | New notice | $21,734,014 | $21,734,014 | 25 | Jul 7, 2025 | sec.gov | |
| Nov 3, 2023 | Amendment | $30,278,002 | $30,278,002 | 32 | Aug 8, 2023 | sec.gov | |
| Nov 3, 2023 | New notice | $30,278,002 | $30,278,002 | 32 | Aug 8, 2023 | sec.gov | |
| Aug 14, 2023 | New notice | $30,034,997 | $30,034,997 | 31 | Aug 8, 2023 | sec.gov | |
| Oct 15, 2020 | New notice | $25,425,007 | $25,425,007 | 17 | Oct 6, 2020 | sec.gov | |
| Jun 7, 2017 | New notice | $8,075,000 | $8,075,000 | 5 | May 30, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Amarpreet Sawhney | Executive Officer | |
| Henry Chen | Director | |
| Tasneem Dohadwala | Director | |
| Farhad Khosravi | Director | |
| Darshana Zaveri | Director | |
| Steven Cagnetta | Executive Officer | |
| Sean Cheng | Director | |
| Daniel Davis | Director | |
| Sean Boyle | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jul 27, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Instylla, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.